Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. - Pitot,H.C.; Wender,D.B.; O'Connel,M.J.; Schroeder,G.; Goldberg,R.M.; Rubin,J. (J. Clin. Oncol., 1997)